Galectin Therapeutics (GALT) Interest Coverage Ratio (2018 - 2026)

Galectin Therapeutics' Interest Coverage Ratio history runs 9 years deep, the most recent figure standing at 2.05 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 54.71% year-over-year to 2.05; the TTM figure through Mar 2026 stood at 2.15 (up 67.1% YoY), while the FY2025 annual figure was 2.74, up 64.22% from the prior year.
• Interest Coverage Ratio was 2.05 for Q1 2026 at Galectin Therapeutics, down from 1.74 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 1.74 in Q4 2025 to a low of 43.77 in Q1 2022.
• Historically, Interest Coverage Ratio has averaged 14.93 across 5 years, with a median of 9.17 in 2024.
• Biggest YoY gain for Interest Coverage Ratio was 97.44% in 2022; the steepest drop was 26.47% in 2022.
• A 5-year view of Interest Coverage Ratio shows it stood at 34.52 in 2022, then jumped by 67.3% to 11.29 in 2023, then surged by 36.17% to 7.2 in 2024, then soared by 75.91% to 1.74 in 2025, then declined by 18.17% to 2.05 in 2026.
• The last three Interest Coverage Ratio figures came in at 2.05 (Q1 2026), 1.74 (Q4 2025), and 2.31 (Q3 2025), per Business Quant data.